Virpax Pharmaceuticals (VRPX) Short Interest Ratio & Short Volume $0.06 +0.03 (+164.29%) As of 01:10 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Virpax Pharmaceuticals Short Interest DataVirpax Pharmaceuticals (VRPX) has a short interest of 37,100 shares, representing 0.79% of the float (the number of shares available for trading by the public). This marks a 18.15% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.2, indicating that it would take 1.2 days of the average trading volume of 185,659 shares to cover all short positions.Current Short Interest37,100 sharesPrevious Short Interest31,400 sharesChange Vs. Previous Month+18.15%Dollar Volume Sold Short$11.72 thousandShort Interest Ratio1.2 Days to CoverLast Record DateJune 30, 2025Outstanding Shares1,242,000 sharesShort Percent of Float0.79%Today's Trading Volume517 sharesAverage Trading Volume185,659 sharesToday's Volume Vs. Average0% Short Selling Virpax Pharmaceuticals? Sign up to receive the latest short interest report for Virpax Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartVRPX Short Interest Over TimeVRPX Days to Cover Over TimeVRPX Percentage of Float Shorted Over Time Virpax Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/202537,100 shares $11.72 thousand +18.2%0.8%1.2 $0.32 6/15/202531,400 shares $7.29 thousand +119.6%0.7%1.3 $0.23 5/31/202514,300 shares $3.51 thousand -3.4%0.3%0.6 $0.25 5/15/202514,800 shares $3.58 thousand +0.7%N/A0.8 $0.24 4/30/202514,700 shares $3.90 thousand -48.4%N/A0.5 $0.27 4/15/202528,500 shares $6.56 thousand -91.1%N/A0.1 $0.23 3/31/2025319,800 shares $383.76 thousand +1,284.4%26.2%0.8 $1.20 3/15/202523,100 shares $96.15 thousand -97.6%1.9%0.1 $4.16 2/28/2025955,300 shares $229.27 thousand -39.2%3.7%0.2 $0.24 2/15/20251,570,000 shares $512.29 thousand +148.7%8.7%0.2 $0.33 Get the Latest News and Ratings for VRPX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Virpax Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/2025631,300 shares $197.03 thousand +437.3%3.6%0.2 $0.31 1/15/2025117,500 shares $41.13 thousand -74.3%0.8%0 $0.35 12/31/2024457,500 shares $173.80 thousand +90.3%3.2%0.1 $0.38 12/15/2024240,400 shares $96.16 thousand -37.8%3.1%0.1 $0.40 11/30/2024386,500 shares $178.18 thousand +22.7%5.1%0.1 $0.46 11/15/2024315,000 shares $193.47 thousand -10.2%4.2%0.1 $0.61 10/31/2024350,900 shares $257.21 thousand -38.0%7.6%1.2 $0.73 10/15/2024565,500 shares $249.95 thousand +46.7%12.3%1.5 $0.44 9/30/2024385,600 shares $267.76 thousand -7.2%8.4%0.1 $0.69 9/15/2024415,300 shares $344.03 thousand -20.6%9.1%0.1 $0.83 8/31/2024523,200 shares $426.51 thousand +241.1%11.4%0.1 $0.82 8/15/2024153,400 shares $130.24 thousand -42.9%3.3%0 $0.85 7/31/2024268,400 shares $327.45 thousand -57.5%6.2%0 $1.22 7/15/2024631,600 shares $675.81 thousand +1,625.7%14.8%0.1 $1.07 6/30/202436,600 shares $18.93 thousand +28.4%1.5%0 $0.52 6/15/202428,500 shares $19.53 thousand -49.7%1.2%0.2 $0.69 5/31/202456,700 shares $39.69 thousand -28.8%2.8%0.6 $0.70 5/15/202479,600 shares $62.09 thousand +907.6%5.1%0.9 $0.78 4/30/20247,900 shares $21.41 thousand -46.6%0.9%0.3 $2.71 4/15/202414,800 shares $52.25 thousand -50.3%1.7%0.6 $3.53 3/31/202429,800 shares $126.98 thousand +24.7%3.4%1.3 $4.26 3/15/202423,900 shares $99.66 thousand +119.3%2.8%1 $4.17 2/29/202410,900 shares $33.27 thousand -82.5%1.3%0.3 $3.05 2/15/202462,400 shares $22.94 thousand -12.2%0.7%0.2 $0.37 1/31/202471,100 shares $23.39 thousand +38.1%0.8%0.2 $0.33 1/15/202451,500 shares $13.75 thousand -44.1%0.6%0.2 $0.27 12/31/202392,100 shares $29.48 thousand +479.3%1.1%0.3 $0.32 12/15/202315,900 shares $6.22 thousand -58.4%0.2%0.1 $0.39 11/30/202338,200 shares $15.27 thousand -30.3%0.4%0.7 $0.40 11/15/202354,800 shares $40.66 thousand -8.8%0.6%2.1 $0.74Market Panic: Trump Just Dropped a Bomb on Your Stocks (Ad)tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.Don't wait for the next drop to wipe you out. Get the FREE Guide Before Markets Open Tomorrow 10/31/202360,100 shares $42.98 thousand +110.1%0.7%2.4 $0.72 10/15/202328,600 shares $23.46 thousand -40.3%0.3%1.1 $0.82 9/30/202347,900 shares $38.32 thousand +197.5%0.6%2.3 $0.80 9/15/202316,100 shares $12.70 thousand -37.6%0.2%0.7 $0.79 8/31/202325,800 shares $22.19 thousand -22.8%0.3%0.8 $0.86 8/15/202333,400 shares $29.89 thousand -20.1%0.4%1 $0.90 7/31/202341,800 shares $37.20 thousand +1.7%0.5%1.3 $0.89 7/15/202341,100 shares $40.28 thousand -48.1%0.5%1.3 $0.98 6/30/202379,200 shares $85.54 thousand +56.8%0.9%2.6 $1.08 6/15/202350,500 shares $46.46 thousand -35.2%0.6%1.8 $0.92 5/31/202377,900 shares $61.14 thousand -26.1%0.9%4.2 $0.78 5/15/2023105,400 shares $90.65 thousand +22.3%1.2%6.1 $0.86 4/30/202386,200 shares $61.25 thousand +2.9%1.0%4.1 $0.71 4/15/202383,800 shares $64.29 thousand -7.7%1.0%2.1 $0.77 3/31/202390,800 shares $71.28 thousand +7.3%1.0%2.3 $0.79 3/15/202384,600 shares $67.68 thousand +6.8%1.0%1.8 $0.80 2/28/202379,200 shares $74.68 thousand -40.4%0.9%1.6 $0.94 2/15/2023132,900 shares $145.34 thousand +285.2%1.6%2.6 $1.09 1/31/202334,500 shares $34.15 thousand +1.8%0.4%0.7 $0.99 1/15/202333,900 shares $28.14 thousand -18.9%0.4%0.9 $0.83 12/30/202241,800 shares $26.01 thousand -51.1%0.5%1 $0.62 12/15/202285,400 shares $68.32 thousand +100.9%1.0%2.3 $0.80 11/30/202242,500 shares $35.70 thousand +21.1%0.5%1.2 $0.84 11/15/202235,100 shares $30.11 thousand +19.0%0.4%1 $0.86 10/31/202229,500 shares $31.57 thousand +16.6%0.3%0.7 $1.07 10/15/202225,300 shares $27.07 thousand -39.3%0.3%0.5 $1.07 9/30/202241,700 shares $49.62 thousand +37.6%0.5%0.9 $1.19 9/15/202230,300 shares $39.69 thousand +5.6%0.4%0.6 $1.31 8/31/202228,700 shares $36.45 thousand -22.9%0.3%0.5 $1.27 8/15/202237,200 shares $62.50 thousand -45.7%0.4%0.6 $1.68 7/31/202268,500 shares $104.12 thousand +78.9%0.8%0.8 $1.52 7/15/202238,300 shares $62.05 thousand -41.1%0.5%0.3 $1.62 6/30/202265,000 shares $109.20 thousand -15.1%0.8%0.4 $1.68 6/15/202276,600 shares $107.24 thousand -12.6%0.9%0.5 $1.40 5/31/202287,600 shares $124.39 thousand -35.0%1.0%0.5 $1.42 5/15/2022134,800 shares $180.63 thousand +61.8%1.5%0.8 $1.34 4/30/202283,300 shares $147.44 thousand +1.0%1.0%0.5 $1.77 4/15/202282,500 shares $165.83 thousand +32.4%0.9%0.6 $2.01 3/31/202262,300 shares $138.31 thousand +3.2%0.7%0.4 $2.22 3/15/202260,400 shares $121.40 thousand -4.9%0.7%0.3 $2.01 2/28/202263,500 shares $137.80 thousand +15.9%0.7%0.1 $2.17 2/15/202254,800 shares $126.59 thousand -22.6%0.6%0.1 $2.31 1/31/202270,800 shares $150.80 thousand +17.8%0.8%0.1 $2.13 1/15/202260,100 shares $172.49 thousand -70.4%0.7%0.1 $2.87 12/31/2021203,000 shares $696.29 thousand -30.7%N/A0.2 $3.43 12/15/2021293,000 shares $1.13 million +222.0%3.3%0.3 $3.85 11/30/202191,000 shares $425.88 thousand -60.5%1.0%0.1 $4.68 11/15/2021230,100 shares $991.73 thousand -3.6%2.6%0.2 $4.31 10/29/2021238,800 shares $998.18 thousand +8.2%2.7%0.1 $4.18 10/15/2021220,700 shares $988.74 thousand -25.2%2.5%0 $4.48Market Panic: Trump Just Dropped a Bomb on Your Stocks (Ad)tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.Don't wait for the next drop to wipe you out. Get the FREE Guide Before Markets Open Tomorrow 9/30/2021294,900 shares $1.42 million -11.1%3.3%0.1 $4.80 9/15/2021331,600 shares $2.00 million +35.2%6.8%0.1 $6.02 8/31/2021245,200 shares $4.68 million +103.8%11.9%0 $19.10 8/13/2021120,300 shares $544.96 thousand No Change5.8%0 $4.53 VRPX Short Interest - Frequently Asked Questions What is Virpax Pharmaceuticals' current short interest? Short interest is the volume of Virpax Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of June 30th, investors have sold 37,100 shares of VRPX short. 0.79% of Virpax Pharmaceuticals' shares are currently sold short. Learn More on Virpax Pharmaceuticals' current short interest. What is a good short interest ratio for Virpax Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VRPX shares currently have a short interest ratio of 1.0. Learn More on Virpax Pharmaceuticals's short interest ratio. What is a good short interest percentage for Virpax Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.79% of Virpax Pharmaceuticals' floating shares are currently sold short. Is Virpax Pharmaceuticals' short interest increasing or decreasing? Virpax Pharmaceuticals saw a increase in short interest in the month of June. As of June 30th, there was short interest totaling 37,100 shares, an increase of 18.2% from the previous total of 31,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Virpax Pharmaceuticals' short interest compare to its competitors? 0.79% of Virpax Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Virpax Pharmaceuticals: Salarius Pharmaceuticals, Inc. (33.45%), Bio-Path Holdings, Inc. (0.10%), Avenue Therapeutics, Inc. (2.48%), Oragenics, Inc. (45.59%), Evofem Biosciences, Inc. (0.03%), Trevena, Inc. (0.38%), Petros Pharmaceuticals, Inc. (3.74%), Sorrento Therapeutics, Inc. (0.67%), Panbela Therapeutics, Inc. (0.00%), ZyVersa Therapeutics, Inc. (9.24%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks. What does it mean to sell short Virpax Pharmaceuticals stock? Short selling VRPX is an investing strategy that aims to generate trading profit from Virpax Pharmaceuticals as its price is falling. VRPX shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Virpax Pharmaceuticals? A short squeeze for Virpax Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of VRPX, which in turn drives the price of the stock up even further. How often is Virpax Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VRPX, twice per month. The most recent reporting period available is June, 30 2025. More Short Interest Resources from MarketBeat Related Companies SLRX Short Squeeze BPTH Short Squeeze ATXI Short Squeeze OGEN Short Squeeze EVFM Short Squeeze TRVN Short Squeeze PTPI Short Squeeze SRNE Short Squeeze PBLA Short Squeeze ZVSA Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VRPX) was last updated on 7/28/2025 by MarketBeat.com Staff From Our PartnersTrump’s $100 Trillion Land Rush Is OnWhat Is "The US: IPO"? You won't hear this on CNBC... but the government may soon open up hundreds of trill...Stansberry Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredI’d rather trade news like this than gamble on hypeReal traders are watching Nvidia’s next move—after U.S. approval to resume chip sales to China. This reversal ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virpax Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Virpax Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
